financetom
Business
financetom
/
Business
/
Luxury car maker JLR abstains from confirming forecast on US tariff uncertainty
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Luxury car maker JLR abstains from confirming forecast on US tariff uncertainty
May 26, 2025 6:40 AM

(Reuters) -India's Tata Motors on Tuesday did not confirm its profitability target for luxury car brand Jaguar Land Rover (JLR), joining other global automakers in abstaining or pulling their forecasts due to the uncertainty around U.S. tariffs.

Imported cars have been a main focus of U.S. President Donald Trump's global trade war. Trump last month imposed a 25% tariff on all foreign-made vehicles sold in the world's second-largest car market, which is UK-based JLR's fastest-growing market.

JLR said it met its earnings before interest and taxes (EBIT) margin target of 8.5% for the year ended March, but abstained from confirming its target of a 10% EBIT margin for the current fiscal year.

"We are assessing our guidance in light of the recent UK-U.S. trade deal announced on May 8 and will provide an update at our investor day on June 16," said parent Tata Motors, which gets about two-thirds of its overall revenue from JLR.

Despite the U.S.-UK trade deal, analysts expect JLR's North America sales to drop this fiscal year, with some noting that the top-selling 'Defender' SUV, which is made in Slovakia, is not covered under the deal.

Automakers globally, including Mercedes-Benz, Fiat-owner Stellantis ( STLA ) and Volvo, have either abstained from issuing or pulled their earnings forecasts.

Still, JLR's sales volumes rose 1.1% in the January-March quarter, helped by strong demand for its SUVs in North America and Europe.

That helped Tata Motors' fourth-quarter profit of 84.70 billion rupees ($993 million) beat analysts' estimates of 74.58 billion rupees, according to data compiled by LSEG.

The company's profit halved from the year-ago quarter, which included a one-time tax benefit.

Tata Motors' shares closed 1.8% lower ahead of the results. ($1 = 85.2750 Indian rupees)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Datadog Insider Sold Shares Worth $1,482,120, According to a Recent SEC Filing
Datadog Insider Sold Shares Worth $1,482,120, According to a Recent SEC Filing
Nov 17, 2025
04:10 PM EST, 11/17/2025 (MT Newswires) -- Shardul Shah, Director, on November 13, 2025, sold 7,916 shares in Datadog ( DDOG ) for $1,482,120. Following the Form 4 filing with the SEC, Shah has control over a total of 358,639 Class A common shares of the company, with 2,106 shares held directly and 356,533 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1561550/000156155025000319/xslF345X05/wk-form4_1763413292.xml ...
Atlanta Braves Holdings Insider Bought Shares Worth $855,679, According to a Recent SEC Filing
Atlanta Braves Holdings Insider Bought Shares Worth $855,679, According to a Recent SEC Filing
Nov 17, 2025
04:09 PM EST, 11/17/2025 (MT Newswires) -- John C Malone, 10% Owner, on November 13, 2025, executed a purchase for 20,387 shares in Atlanta Braves Holdings ( BATRA ) for $855,679. Following the Form 4 filing with the SEC, Malone has control over a total of 461,582 Series A common shares of the company, with 451,405 shares held directly and...
Fox Factory Holding Insider Bought Shares Worth $312,321, According to a Recent SEC Filing
Fox Factory Holding Insider Bought Shares Worth $312,321, According to a Recent SEC Filing
Nov 17, 2025
04:13 PM EST, 11/17/2025 (MT Newswires) -- Michael C. Dennison, Director, Chief Executive Officer, on November 14, 2025, executed a purchase for 22,000 shares in Fox Factory Holding ( FOXF ) for $312,321. Following the Form 4 filing with the SEC, Dennison has control over a total of 246,786 common shares of the company, with 246,786 shares held directly. SEC...
Enanta Pharmaceuticals Q4 revenue rises, helped by higher sales of AbbVie's MAVYRET/MAVIRET
Enanta Pharmaceuticals Q4 revenue rises, helped by higher sales of AbbVie's MAVYRET/MAVIRET
Nov 17, 2025
Overview * Enanta fiscal Q4 revenue missed analyst expectations * Net loss for fiscal Q4 narrows year-over-year, indicating improved financial performance * Company maintains strong cash position, bolstered by October 2025 public offering Outlook * Enanta plans to file IND for EPS-3903 in the second half of 2026 * Company expects cash and revenue to fund operations into fiscal 2029...
Copyright 2023-2026 - www.financetom.com All Rights Reserved